Navigation Links
Solving the riddle of nature's perfect spring
Date:3/1/2011

Scientists have unravelled the shape of the protein that gives human tissues their elastic properties in what could lead to the development of new synthetic elastic polymers.

University of Manchester researchers, working with colleagues in Australia and the United States, used state-of-the-art techniques to reveal the structure of tropoelastin, the main component of elastin.

Elastin allows tissues in humans and other mammals to stretch, for example when the lungs expand and contract for respiration or when arteries widen and narrow over the course of a billion heart beats.

The study, published in the science journal PNAS (March issue), revealed how evolution has triumphed where engineering has so far failed by generating a molecule with near-perfect elasticity that will last a lifetime.

"All mammals rely on elastin to provide their tissues with the ability to stretch and then return to their original shape," said researcher Dr Clair Baldock, from the University of Manchester's Wellcome Trust Centre for Cell Matrix Research. "This high level of physical performance demanded of elastin vastly exceeds and indeed outlasts all human-made elastics.

"It is the co-ordinated assembly of many tropoelastins into elastin that gives tissues their stretchy properties and this exquisite assembly helps to generate elastic tissues as diverse as artery, lung and skin.

"We discovered that tropoelastin is a curved, spring-like molecule with a 'foot' region to facilitate attachment to cells. Stretching and relaxing experiments showed that the molecule had the extraordinary capacity to extend to eight-times its initial length and can then return to its original shape with no loss of energy, making it a near-perfect spring."

She added: "Elastics are used in applications as diverse as clothing, vehicles, tissue engineering and even space travel, so understanding how the structure of tropoelastin creates its exceptional elastic properties will hopefully enable the development of synthetic 'elastin-like' polymers with potentially wide-ranging applications and benefits."

Initiator and research project leader Tony Weiss, Professor in the School of Molecular Bioscience, The University of Sydney, added: "Tropoelastin is a tiny protein 'nanospring' in the human body. Our bodies assemble these nanosprings to put elasticity into tissues like skin, blood vessels and lung.

"Our finding is the result of more than a decade of international collaboration. Our scientific teamwork spans Australia, the UK, USA and Europe. Tropoelastin's extraordinary capacity to extend to eight-times its initial length and then return to its original shape, with no loss of energy, is nature showing us how to make an ideal nanospring."


'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Related biology news :

1. Bowman Global Change says public engagement critical to solving climate crisis
2. Brains problem-solving function at work when we daydream
3. Solving the puzzle of the BK ion channel
4. Toward resolving Darwins abominable mystery
5. TriCipher myOneLogin SignatureBook Offers Digital Signatures On-Demand
6. Genetic signatures provide new direction in liver cancer
7. Beverages leave geographic signatures that can track peoples movements
8. Genome signatures enable tracking of algal complexity
9. Blood signatures to diagnose infection
10. CIC Announces Upcoming Webinar: Insurance Consumer Expectations; Customer Experience & Self-Service Will Hit New Highs in 2011! The Role eSignatures Will Play in Meeting that Demand
11. Study identifies new genetic signatures of breast cancer drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... ANGELES , Feb. 16, 2017   ... ), a clinical-stage biotechnology company developing first-in-class biological ... announced that it has elected to terminate its ... natriuretic peptide receptor agonists, including Cenderitide. ... strategic move as we prioritize our efforts to ...
(Date:2/16/2017)...  Champions Oncology, Inc. (NASDAQ: CSBR ), ... advanced technology solutions and products to personalize the development ... of new cohorts of PDX models to their existing ... Champions, product line in hepatocellular cancer, breast cancer, castrate ... non-small cell lung cancer (including EGFR mutation; ALK/ROS1 positive) ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... Research Inc. has further extended its industry leading Biochemistry Services specifically targeting ... state-of-the-art cGMP techniques and methods for the biochemical and biosimilar characterization ...
(Date:2/15/2017)... WASHINGTON, Feb. 15, 2017  Vanda Pharmaceuticals Inc. ... results for the fourth quarter and full year ... an exceptional year for Vanda as we continued ... and secured long-term exclusivity for Fanapt," said Mihael ... addition, our emerging pipeline with important 2017 milestones ...
Breaking Biology Technology: